Insider · CIK 0001306119
Kevin T Conroy
ceopresidentofficerdirector
Files at ABT (ABBOTT LABORATORIES), ALGN (ALIGN TECHNOLOGY INC), EXAS (EXACT SCIENCES CORP). First filing Nov 13, 2024, latest Nov 13, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$1.0M bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | EXASbuy EXACT SCIENCES CORP | $1.0M 19,500 shares | +2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | ABT ABBOTT LABORATORIES | AGrant or award Stock Equivalent Unitsderivative | +318 | $98.83 | $31k | 551 | 10 d ago |
| Sep 23, 2026 | ABT ABBOTT LABORATORIES | FTax withholding Common shares without par value | -52,507 | $103.99 | $5.5M | 81,230 | 17 d ago |
| Dec 23, 2025 | EXAS EXACT SCIENCES CORP | AGrant or award Common Stock | +244,931 | $0.00 | $0 | 1,101,519 | Dec 30, 2025 |
| Dec 23, 2025 | EXAS EXACT SCIENCES CORP | FTax withholding Common Stock | -115,118 | $101.82 | $12M | 986,401 | Dec 30, 2025 |
| Dec 23, 2025 | EXAS EXACT SCIENCES CORP | AGrant or award Common Stock | +138,326 | $0.00 | $0 | 1,124,727 | Dec 30, 2025 |
| Dec 23, 2025 | EXAS EXACT SCIENCES CORP | FTax withholding Common Stock | -65,014 | $101.82 | $6.6M | 1,059,713 | Dec 30, 2025 |
| Dec 23, 2025 | EXAS EXACT SCIENCES CORP | AGrant or award Common Stock | +330,674 | $0.00 | $0 | 155,417 | Dec 30, 2025 |
| Dec 23, 2025 | EXAS EXACT SCIENCES CORP | FTax withholding Common Stock | -155,417 | $101.82 | $16M | 1,234,970 | Dec 30, 2025 |
| May 21, 2025 | ALGN ALIGN TECHNOLOGY INC | MOption exercise Common Stock | +1,148 | $0.00 | $0 | 1,808 | May 22, 2025 |
| May 21, 2025 | ALGN ALIGN TECHNOLOGY INC | MOption exercise Restricted Stock Unitsderivative | -1,148 | $0.00 | $0 | 0 | May 22, 2025 |
| May 21, 2025 | ALGN ALIGN TECHNOLOGY INC | AGrant or award Restricted Stock Unitsderivative | +1,745 | $0.00 | $0 | 1,745 | May 22, 2025 |
| Mar 7, 2025 | EXAS EXACT SCIENCES CORP | MOption exercise Common Stock | +66,723 | $22.38 | $1.5M | 1,203,269 | Mar 10, 2025 |
| Mar 7, 2025 | EXAS EXACT SCIENCES CORP | FTax withholding Common Stock | -48,929 | $47.06 | $2.3M | 1,154,340 | Mar 10, 2025 |
| Mar 7, 2025 | EXAS EXACT SCIENCES CORP | MOption exercise Stock Options (Right to Buy)derivative | -66,723 | $0.00 | $0 | 0 | Mar 10, 2025 |
| Feb 28, 2025 | EXAS EXACT SCIENCES CORP | MOption exercise Common Stock | +18,143 | $0.00 | $0 | 1,133,326 | Mar 4, 2025 |
| Feb 28, 2025 | EXAS EXACT SCIENCES CORP | FTax withholding Common Stock | -8,528 | $47.82 | $408k | 1,124,798 | Mar 4, 2025 |
| Feb 28, 2025 | EXAS EXACT SCIENCES CORP | MOption exercise Common Stock | +22,167 | $0.00 | $0 | 1,146,965 | Mar 4, 2025 |
| Feb 28, 2025 | EXAS EXACT SCIENCES CORP | FTax withholding Common Stock | -10,419 | $47.82 | $498k | 1,136,546 | Mar 4, 2025 |
| Feb 28, 2025 | EXAS EXACT SCIENCES CORP | MOption exercise Restricted Stock Unitsderivative | -18,143 | $0.00 | $0 | 36,286 | Mar 4, 2025 |
| Feb 28, 2025 | EXAS EXACT SCIENCES CORP | MOption exercise Restricted Stock Unitsderivative | -22,167 | $0.00 | $0 | 66,504 | Mar 4, 2025 |
| Feb 25, 2025 | EXAS EXACT SCIENCES CORP | MOption exercise Common Stock | +13,180 | $0.00 | $0 | 1,121,378 | Feb 26, 2025 |
| Feb 25, 2025 | EXAS EXACT SCIENCES CORP | FTax withholding Common Stock | -6,195 | $51.28 | $318k | 1,115,183 | Feb 26, 2025 |
| Feb 24, 2025 | EXAS EXACT SCIENCES CORP | AGrant or award Restricted Stock Unitsderivative | +111,146 | $0.00 | $0 | 111,146 | Feb 26, 2025 |
| Feb 25, 2025 | EXAS EXACT SCIENCES CORP | MOption exercise Restricted Stock Unitsderivative | -13,180 | $0.00 | $0 | 13,181 | Feb 26, 2025 |
| Feb 19, 2025 | EXAS EXACT SCIENCES CORP | MOption exercise Common Stock | +10,374 | $0.00 | $0 | 1,084,565 | Feb 21, 2025 |
| Feb 19, 2025 | EXAS EXACT SCIENCES CORP | FTax withholding Common Stock | -3,271 | $49.63 | $162k | 1,081,294 | Feb 21, 2025 |
| Feb 20, 2025 | EXAS EXACT SCIENCES CORP | AGrant or award Common Stock | +48,044 | $0.00 | $0 | 1,129,338 | Feb 21, 2025 |
| Feb 20, 2025 | EXAS EXACT SCIENCES CORP | FTax withholding Common Stock | -21,140 | $50.48 | $1.1M | 1,108,198 | Feb 21, 2025 |
| Feb 19, 2025 | EXAS EXACT SCIENCES CORP | MOption exercise Restricted Stock Unitsderivative | -10,374 | $0.00 | $0 | 0 | Feb 21, 2025 |
| Nov 13, 2024 | EXAS EXACT SCIENCES CORP | POpen-market purchase Common Stock | +19,500 | $51.35 | $1.0M | 1,074,191 | Nov 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.